We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
A picture of Anna MacDonald

Anna MacDonald profile page

Senior Science Editor

 at Technology Networks


After obtaining a first-class honors degree in biological sciences from the University of East Anglia, Anna worked as a scientific conference producer before joining Technology Networks. As part of her role, Anna helps to coordinate coverage, working with key opinion leaders from industry and academia to produce content across all communities.


Education


University of East Anglia  


Areas of Expertise



Got a Question for Anna MacDonald?


Get in touch using the contact form linked here and we’ll get back to you shortly



Published Content
Total: 318
Driving Change in Rare Disease Diagnostics  content piece image
Industry Insight

Driving Change in Rare Disease Diagnostics

In this two-part interview series, Technology Networks delves deeper into the diagnostic odyssey many rare disease patients face and explores current efforts to develop improved therapies for these patients.
Moving Towards the Next Era in Rare Disease Therapeutics content piece image
Industry Insight

Moving Towards the Next Era in Rare Disease Therapeutics

In this two-part interview series, Technology Networks explores some of the reasons behind the difficulties diagnosing and treating rare diseases, and finds out more about recent developments to improve options for patients.
Targeting EBV-Infected Cells To Treat Multiple Sclerosis content piece image
Industry Insight

Targeting EBV-Infected Cells To Treat Multiple Sclerosis

Technology Networks spoke to Atara’s chief medical officer, AJ Joshi, to learn more about ATA188 – an off-the-shelf, allogeneic T-cell immunotherapy – and how it could revolutionize treatment for MS patients.
Streamlining Urinalysis Workflows content piece image
Industry Insight

Streamlining Urinalysis Workflows

To learn more about the impact of manual inspection on urinalysis labs and how automated solutions such as the DxU Iris are helping to streamline workflows, Technology Networks spoke to Jose Crespo, senior director sales and marketing Europe, Beckman Coulter.
Women in Science: Perspectives From Industry content piece image
Industry Insight

Women in Science: Perspectives From Industry

In honor of International Day of Women and Girls in Science 2022, Technology Networks interviewed three women who have built successful careers within the scientific industry, to learn about their career paths and the reasons they chose to work in industry.
The Impact of Industry and Technology on the Next Generation of Scientists content piece image
Listicle

The Impact of Industry and Technology on the Next Generation of Scientists

In this listicle, we summarize the findings from the "Science Futures" project and highlight three areas in which industry and technology are impacting the next generation of scientists.
A One-Stop Platform To Drive Progress in Gene Therapy Development content piece image
Industry Insight

A One-Stop Platform To Drive Progress in Gene Therapy Development

In this interview, Dr. Ren discusses some of the challenges that currently exist when developing gene therapies and explores how Cyagen’s one-stop gene therapy platform can help to address them.
Gene-Edited Stem Cell-Derived Therapies – A Functional Cure for T1D? content piece image
Industry Insight

Gene-Edited Stem Cell-Derived Therapies – A Functional Cure for T1D?

Technology Networks spoke with Michael Yang, president and chief executive officer of ViaCyte, to learn more about the development of a stem cell-derived therapy for the treatment of T1D and the technology behind it.
Metabolomics-Based Blood Test Could Enable Earlier Detection of Cancer content piece image
Article

Metabolomics-Based Blood Test Could Enable Earlier Detection of Cancer

Dr. James Larkin discusses the benefits of biofluid metabolomics and how an NMR-based approach could help to improve the way that cancer is detected and monitored in patients with nonspecific symptoms.
How Do Spreadsheets Hold Back Pharma Innovation? content piece image
Industry Insight

How Do Spreadsheets Hold Back Pharma Innovation?

Technology Networks spoke to Jesse Harris to learn why spreadsheets can be a bottleneck for pharma research and explore how they compare to laboratory informatics tools.
Advertisement